Trappsol Cyclo – Patient Worthy

source: pixabay.com

New Trappsol Cyclo Safety and Efficacy Data Available for NPC1

Post author:Jessica Lynn
Post published:August 6, 2021
Post category:Niemann-Pick Disease Niemann-Pick Type C Disease

On July 30, 2021, biopharmaceutical company Cyclo Therapeutics shared that it had released new and promising data regarding the safety, efficacy, and tolerability of Trappsol® Cyclo™ ("Trappsol Cyclo") for patients with…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More